Search Contact
OWNERSHIP

09/01/2019 18:27 Relevant Fact: Significant Participations
Significant shareholdings. December 31, 2018

Shareholders % direct shareholding % indirect shareholding (*) % total shareholding
KANEKA EUROPE HOLDING COMPANY NV 37,77% 37,77%
D. Miquel Àngel Bonachera Sierra 9,91% 9,91%
D. Sergi Audivert Brugué 9,91% 9,91%
D. Luis Sánchez Lafuente-Mario 8,87% 1,28% 10,15%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.28% through the Bio Littletec Society, S.L.

04/07/2018 23:38 Relevant Fact: Significant Participations
Significant shareholdings. June 30, 2018

Shareholders % direct shareholding % indirect shareholding % total shareholding
KANEKA EUROPE HOLDING COMPANY NV 37,77% 37,77%
D. Miquel Àngel Bonachera Sierra 9,91% 9,91%
D. Sergi Audivert Brugué 9,91% 9,91%
D. Luis Sánchez Lafuente-Mario 8,87% 0,92% 9,79%
Biolittletec, S.L. 1,15% 1,15%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital

09/04/2018 20:53 Relevant Fact: Significant Participations
Kaneka Europe Holding Company NV increases its participation in AB-Biotics

Shareholders % direct shareholding % indirect shareholding % total shareholding
Kaneka Europe Holding Company NV 34,05%
Miquel Àngel Bonachera Sierra 10,11%
Sergi Audivert Brugué 9,91% 10,11%
Luis Sánchez Lafuente 8,87% 0,92% 10,10%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital

10/01/2018 15:21 Relevant Fact: Significant Participations
Significant shareholdings. December 31, 2017

Shareholders % direct shareholding (*)
D. Miquel Àngel Bonachera Sierra 10,11%
D. Sergi Audivert Brugué 10,11%
D. Luis Sánchez-Lafuente Mariol 7,63%
Seed Capital Fund, S.L. 5,26%
Institut Català de Finances Capital SGECR, S.A.U 3,29%
INFEMA, S.A. 1,50%
Gestión y Administración Mobiliaria, S.A. 5,16%
Corporación Ivamosa, S.A. 5,16%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 0.92% through the Bio Littletec Society, S.L.

05/07/2017 13:55 Relevant Fact: Significant Participations
Significant shareholdings. June 30, 2017.

Shareholders % direct shareholding (*)
D. Miquel Àngel Bonachera Sierra 10,11%
D. Sergi Audivert Brugué 10,11%
D. Luis Sánchez-Lafuente Mariol 7,63%
Seed Capital Fund, S.L. 5,26%
Institut Català de Finances Capital SGECR, S.A.U 3,29%
INFEMA, S.A. 1,50%
Gestión y Administración Mobiliaria, S.A. 5,16%
Corporación Ivamosa, S.A. 5,16%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 0.92% through the Bio Littletec Society, S.L.

10/01/2017 16:10 Relevant Fact: Significant Participations
Significant shareholdings. December 31, 2016.

Shareholders % direct shareholding
D. Miquel Àngel Bonachera Sierra 10,11%
D. Sergi Audivert Brugué 10,11%
D. Luis Sánchez-Lafuente Mariol 7,63%
Seed Capital Fund, S.L. 5,26%
Institut Català de Finances Capital SGECR, S.A.U 3,29%
INFEMA, S.A. 1,50%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital

03/10/2016 17:32 Relevant Fact: Significant Participations
Significant shareholdings update.

Shareholders % direct shareholding (*)
D. Miquel Àngel Bonachera Sierra 10,11%
D. Sergi Audivert Brugué 10,11%
D. Luis Sánchez-Lafuente Mariol 7,63%
Seed Capital Fund, S.L. 5,26%
Institut Català de Finances Capital SGECR, S.A.U 3,29%
INFEMA, S.A. 1,50%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 0.92% through the Bio Littletec Society, S.L.

06/07/2016 17:32 Relevant Fact: Significant Participations
Significant shareholdings. June 30, 2016.

Shareholders % direct shareholding (*)
D. Miquel Àngel Bonachera Sierra 13,07%
D. Sergi Audivert Brugué 13,07%
D. Luis Sánchez-Lafuente Mariol 9,29%
Seed Capital Fund, S.L. 5,21%
Institut Català de Finances Capital SGECR, S.A.U 3,88%
INFEMA, S.A. 1,97%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.51% through the Bio Littletec Society, S.L.

04/01/2016 17:32 Relevant Fact: Significant Participations
Significant shareholdings.

Shareholders % direct shareholding (*)
D. Miquel Àngel Bonachera Sierra 13,07%
D. Sergi Audivert Brugué 13,07%
D. Luis Sánchez-Lafuente Mariol 9,29%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.21% through the Bio Littletec Society, S.L.

03/07/2015 09:40 Relevant Fact: Significant Participations
Significant shareholdings. June 30, 2015.

Shareholders % direct shareholding (*)
D. Miquel Àngel Bonachera Sierra 13,07%
D. Sergi Audivert Brugué 13,07%
D. Luis Sánchez-Lafuente Mariol 9,29%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.21% through the Bio Littletec Society, S.L.

08/01/2015 15:20 Relevant Fact: Significant Participations
Significant shareholdings.

Shareholders % direct shareholding (*)
D. Miquel Àngel Bonachera Sierra 13,24%
D. Sergi Audivert Brugué 13,24%
D. Luis Sánchez-Lafuente Mariol 9,30%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.21% through the Bio Littletec Society, S.L.

09/07/2014 14:15 Relevant Fact: Significant Participations
Significant shareholdings.

Shareholders % direct shareholding (*)
D. Miquel Àngel Bonachera Sierra 13,24%
D. Sergi Audivert Brugué 13,24%
D. Luis Sánchez-Lafuente Mariol 9,30%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.21% through the Bio Littletec Society, S.L.

08/01/2014 20:15 Relevant Fact: Significant Participations
Significant shareholdings.

Shareholders % direct shareholding (*)
D. Miquel Àngel Bonachera Sierra 13,26%
D. Sergi Audivert Brugué 13,26%
D. Luis Sánchez-Lafuente Mariol 9,30%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.21% through the Bio Littletec Society, S.L.

16/10/2013 18:47 Relevant Fact: Significant Participations
Significant shareholdings.

Shareholders % direct shareholding (*)
D. Miquel Àngel Bonachera Sierra 13,26%
D. Sergi Audivert Brugué 13,26%
D. Luis Sánchez-Lafuente Mariol 9,30%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.21% through the Bio Littletec Society, S.L.

01/07/2013 17:51 Relevant Fact: Significant Participations
Significant shareholdings.

Shareholders % direct shareholding (*)
D. Miquel Àngel Bonachera Sierra 14,02%
D. Sergi Audivert Brugué 14,02%
D. Luis Sánchez-Lafuente Mariol 9,83%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.28% through the Bio Littletec Society, S.L.

11/03/2013 19:16 Relevant Fact: Significant Participations
Significant shareholdings.

Shareholders % direct shareholding (*)
D. Miquel Àngel Bonachera Sierra 14,02%
D. Sergi Audivert Brugué 14,02%
D. Luis Sánchez-Lafuente Mariol 9,83%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.28% through the Bio Littletec Society, S.L.

09/01/2013 10:30 Relevant Fact: Significant Participations
Significant shareholdings.

Shareholders % direct shareholding (*)
D. Miquel Àngel Bonachera Sierra 17,67%
D. Sergi Audivert Brugué 17,67%
D. Luis Sánchez-Lafuente Mariol 12,29%

Shareholders that held 10% of the share capital of ABBIOTICS S.A, as well as those administrators or executives with more than 1% of the share capital.

(*) Luis Sánchez-Lafuente Mariol indirectly has an additional 1.64% through the Bio Littletec Society, S.L.

Ticker name: ABB:SM
Suscríbete y te avisaremos
de nuestras actualizaciones en investors